Woodstock Corp Reata Pharmaceuticals Inc Transaction History

Woodstock Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	SELL	$22.15 - $42.11 $8,860 - $16,844	-400 Reduced 2.72%	14,285 $0
Q3 2022 Oct 11, 2022	BUY	$19.41 - $36.49 $23,524 - $44,225	1,212 Added 9.0%	14,685 $369,000
Q1 2022 Apr 07, 2022	SELL	$24.12 - $39.6 $16,015 - $26,294	-664 Reduced 4.7%	13,473 $441,000
Q4 2021 Jan 07, 2022	SELL	$25.61 - $110.96 $392,678 - $1.7 Million	-15,333 Reduced 52.03%	14,137 $373,000
Q3 2021 Oct 05, 2021	BUY	$100.0 - $143.02 $184,000 - $263,156	1,840 Added 6.66%	29,470 $2.97 Million
Q2 2021 Jul 06, 2021	BUY	$78.27 - $151.29 $501,945 - $970,222	6,413 Added 30.23%	27,630 $3.91 Million
Q1 2021 Apr 05, 2021	BUY	$94.25 - $132.81 $14,137 - $19,921	150 Added 0.71%	21,217 $2.12 Million
Q4 2020 Jan 06, 2021	SELL	$102.03 - $184.62 $84,174 - $152,311	-825 Reduced 3.77%	21,067 $2.6 Million
Q3 2020 Oct 02, 2020	BUY	$93.53 - $163.34 $634,413 - $1.11 Million	6,783 Added 44.89%	21,892 $2.13 Million
Q4 2019 Jan 13, 2020	SELL	$74.57 - $217.92 $411,253 - $1.2 Million	-5,515 Reduced 26.74%	15,109 $3.09 Million
Q3 2018 Oct 03, 2018	SELL	$35.64 - $92.06 $110,697 - $285,938	-3,106 Reduced 13.09%	20,624 $1.69 Million
Q2 2018 Jul 23, 2018	BUY	$19.94 - $40.96 $79,321 - $162,938	3,978 Added 20.14%	23,730 $830,000
Q1 2018 Apr 19, 2018	BUY	$20.0 - $30.19 $92,720 - $139,960	4,636 Added 30.67%	19,752 $405,000
Q4 2017 Jan 24, 2018	BUY	$22.39 - $33.27 $338,447 - $502,909	15,116	15,116 $428,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

Stay updated on Woodstock Corp with notifications on news.